A Phase I Study of Aromatic L-Amino Acid Decarboxylase Gene Therapy for Parkinson's Disease

Molecular Therapy- United States

doi 10.1038/mt.2010.135

Full Text

Abstract

Available in

Date

Authors

Publisher

Elsevier BV

Related search

Aromatic L‐Amino Acid Decarboxylase Gene Therapy Enhances Levodopa Response in Parkinson's Disease

Movement Disorders
Neurology
2020English

Aromatic L-Amino Acid Decarboxylase Deficiency

2020Italian

Distribution of Aromatic L-Amino Acid Decarboxylase Activity in Tissues of Skipjack

Fisheries Science
Aquatic Science
1995English

Urine Organic Acid (UOA) Analysis for the Diagnosis of Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency

Pathology
Forensic MedicinePathology
2020English

MRI-guided Phase 1 Trial of Putaminal AADC Gene Therapy for Parkinson's Disease

Annals of Neurology
Neurology
2019English

Correction of a Rat Model of Parkinson's Disease by Coexpression of Tyrosine Hydroxylase and Aromatic Amino Acid Decarboxylase From a Helper Virus-Free Herpes Simplex Virus Type 1 Vector

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2003English

Aromatic Amino Acid Hydroxylases and Mental Disease

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1980English

200. Advancing a State of the Art Gene Therapy for Parkinson's Disease

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Heterozygosis in Aromatic Amino Acid Decarboxylase Deficiency: Evidence for a Positive Interallelic Complementation Between R347Q and R358H Mutations

IUBMB Life
BiochemistryGeneticsClinical BiochemistryCell BiologyMolecular Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy